Vascular Biology |
From the Division of Cardiology (K.T., Y.K., K.K., I.N.), Department of Medicine, Wakayama Medical University, Wakayama, Japan, and Tokyo Rosai Hospital (Y.M.), Tokyo, Japan.
Correspondence to Kazushi Tsuda, MD, Division of Cardiology, Department of Medicine, Wakayama Medical University, Kimiidera 811-1, Wakayama 641-8509, Japan. E-mail tsudak{at}mail.wakayama-med.ac.jp
Abstract Many studies have shown that estrogen may exert cardioprotective effects and reduce the risk of hypertension and coronary events. On the other hand, it has been proposed that cell membrane abnormalities play a role in the pathophysiology of hypertension, although it is not clear whether estrogen would influence membrane function in essential hypertension. The present study was performed to investigate the effects of 17ß-estradiol (E2) on membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women. We determined the membrane fluidity of erythrocytes by means of an electron paramagnetic resonance and spin-labeling method. In an in vitro study, E2 significantly decreased the order parameter for 5-nitroxide stearate and the peak height ratio for 16-nitroxide stearate obtained from electron paramagnetic resonance spectra of erythrocyte membranes in normotensive postmenopausal women. The finding indicates that E2 might increase the membrane fluidity of erythrocytes. The effect of E2 was significantly potentiated by the NO donor, S-nitroso-N-acetylpenicillamine, and a cGMP analogue, 8-bromo-cGMP. In contrast, the change in the membrane fluidity evoked by E2 was attenuated in the presence of the NO synthase inhibitor, NG-nitro-L-arginine methyl ester, and asymmetric dimethyl-L-arginine. In hypertensive postmenopausal women, the membrane fluidity of erythrocytes was significantly lower than that in normotensive postmenopausal women. The effect of E2 on membrane fluidity was significantly more pronounced in the erythrocytes of hypertensive postmenopausal women than in the erythrocytes of normotensive postmenopausal women. The results of the present study showed that E2 significantly increased the membrane fluidity and improved the microviscosity of erythrocyte membranes, partially mediated by an NO- and cGMP-dependent pathway. Furthermore, the greater action of E2 in hypertension might be consistent with the hypothesis that E2 could have a beneficial effect in regulating rheological behavior of erythrocytes and could have a crucial role in the improvement of the microcirculation in hypertension.
Key Words: 17ß-estradiol nitric oxide membrane fluidity erythrocytes postmenoapusal women
This article has been cited by other articles:
![]() |
S. Leekumjorn, Y. Wu, A. K. Sum, and C. Chan Experimental and Computational Studies Investigating Trehalose Protection of HepG2 Cells from Palmitate-Induced Toxicity Biophys. J., April 1, 2008; 94(7): 2869 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuda Sex Hormones and Stroke Rehabilitation in Men and Women Stroke, June 1, 2007; 38(6): e32 - e32. [Full Text] [PDF] |
||||
![]() |
K. Tsuda Asymmetric Dimethylarginine and Cerebrovascular Disorders in Humans Stroke, December 1, 2006; 37(12): 2870 - 2870. [Full Text] [PDF] |
||||
![]() |
K. Tsuda A New Hormone Therapy With Drospirenone and NO Production in Postmenopausal Women Hypertension, November 1, 2006; 48(5): e106 - e106. [Full Text] [PDF] |
||||
![]() |
K. Tsuda Surgical Menopause, Salt Sensitivity, and NO Bioavailability in Women Hypertension, September 1, 2006; 48(3): E12 - E12. [Full Text] [PDF] |
||||
![]() |
K. Tsuda Sex Hormones and Carotid Atherosclerosis in the Metabolic Syndrome Stroke, December 1, 2005; 36(12): 2528 - 2528. [Full Text] [PDF] |
||||
![]() |
K. Tsuda, I. Nishio, E. Ros, I. Nunez, A. Perez-Heras, M. Serra, R. Gilabert, E. Casals, and R. Deulofeu Modulation of Endothelial Function by Walnuts and Sex Hormones * Response Circulation, August 17, 2004; 110(7): e73 - e73. [Full Text] [PDF] |
||||
![]() |
K. Tsuda, I. Nishio, P. J. Kelly, and K. L. Furie Homocysteine, Vitamin B6, and Endothelial Dysfunction in Circulatory Disorders * Response Stroke, August 1, 2004; 35(8): 1785 - 1785. [Full Text] [PDF] |
||||
![]() |
K. Tsuda and I. Nishio Serum Homocysteine and Endothelial Dysfunction in Circulatory Disorders in Women Circulation, July 27, 2004; 110(4): e37 - e37. [Full Text] [PDF] |
||||
![]() |
K. Tsuda, I. Nishio, M. Weis, J. P. Cooke, K. Y. Lin, S. N. Panchal, S.Z. Gao, H. A. Valantine, T. N. Kledal, and E. S. Mocarski Sex Hormones and Asymmetric Dimethylarginine in Transplant Arteriosclerosis * Response Circulation, July 20, 2004; 110(3): e21 - e22. [Full Text] [PDF] |
||||
![]() |
K. Tsuda and I. Nishio Hyperinsulinemia and Estrogen-Deficiency as Risk Factors for Stroke in Women Stroke, June 1, 2004; 35(6): e134 - e134. [Full Text] [PDF] |
||||
![]() |
K. Tsuda, I. Nishio, V. Vaccarino, Z. Q. Lin, J. A. Mattera, S. A. Roumanis, S. V. Kasl, J. L. Abramson, and H. M. Krumholz Sex Hormones and Membrane Microviscosity in Elderly Women * Response Circulation, May 11, 2004; 109(18): e218 - e218. [Full Text] [PDF] |
||||
![]() |
K. Tsuda, I. Nishio, T. Kurth, and J. E. Buring Smoking, Estrogen, and Membrane Microviscosity in Women * Response Stroke, April 1, 2004; 35(4): e71 - e71. [Full Text] [PDF] |
||||
![]() |
K. Tsuda, I. Nishio, D. P. Holden, J. E. Cartwright, G. St.J. Whitley, and S. S. Nussey Estrogen and Asymmetric Dimethylarginine in Postmenopausal Women * Response Circulation, March 30, 2004; 109(12): e174 - e174. [Full Text] [PDF] |
||||
![]() |
K. Tsuda, I. Nishio, J. P. Cooke, and M. Stuhlinger Asymmetric Dimethylarginine and Circulatory Disorders in Postmenopausal Women * Response Circulation, February 10, 2004; 109 (5): e35 - e35. [Full Text] [PDF] |
||||
![]() |
K. Tsuda and I. Nishio Role of Estrogens in the Regulation of Membrane Microviscosity Circ. Res., February 6, 2004; 94 (2): e17 - e17. [Full Text] [PDF] |
||||
![]() |
K. Tsuda, M. E. Mussolino, J. H. Madans, and R.F. Gillum Bone Mineral Density, Blood Pressure, and Stroke in Elderly Women * Response Stroke, November 1, 2003; 34 (11): e210 - e211. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |